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Abstract: Ion pairing is a strategy used to increase the permeation of topically applied ionised drugs.
Formation occurs when the electrostatic energy of attraction between oppositely charged ions exceeds
their mean thermal energy, making it possible for them to draw together and attain a critical distance.
These ions then behave as a neutral species, allowing them to partition more readily into a lipid
environment. Partition coefficient studies may be used to determine the potential of ions to pair and
partition into an organic phase but cannot be relied upon to predict flux. Early researchers indicated
that temperature, size of ions and dielectric constant of the solvent system all contributed to the
formation of ion pairs. While size is important, this may be outweighed by improved lipophilicity of
the counter ion due to increased length of the carbon chain. Organic counter ions are more effective
than inorganic moieties in forming ion pairs. In addition to being used to increase permeation, ion
pairs have been used to control and even prevent permeation of the active ingredient. They have also
been used to stabilise solid lipid nanoparticle formulations. Ion pairs have been used in conjunction
with permeation enhancers, and permeation enhancers have been used as counter ions in ion pairing.
This review attempts to show the various ways in which ion pairs have been used in drug delivery
via the skin. It also endeavours to extract and consolidate common approaches in order to inform
future formulations for topical and transdermal delivery.
Keywords: ion pair; topical; counter ions; partition; permeation; porcine; human; skin
1. Introduction
The application of drugs via the skin provides a number of benefits. These include
the potential to provide a steady-state release [1], the avoidance of first-pass metabolism
in the case of transdermal formulations and the localisation of application for topical
formulations [2]. Furthermore, the capacity for rapid cessation in cases of adverse reactions,
the avoidance of side effects related to oral administration [3] and, with particular reference
to non-steroidal anti-inflammatory drugs, the avoidance of gastrointestinal and renal
problems [4] all contribute to the advantages of this delivery route.
Notwithstanding the many benefits, this mechanism of drug delivery needs to ensure
that appropriate quantities of the drug are transported to the target site. The skin, however,
does not offer an easy passage for the delivery of drugs. The outermost layer, known
as the stratum corneum (SC), provides such an effective barrier that in the case of many
topical formulations, only approximately 1–2% of the applied drug or active ingredient
permeates [5].
This is partly due to the majority of pharmaceutical compounds being either weak
acids or bases, with concomitant low aqueous solubility. As the most prevalent drug
delivery system is oral, drugs are frequently developed as salts that ionise at physiological
pH in an effort to facilitate processing and increase bioavailability. This poses a problem for
topical and transdermal drug delivery, because of the lipid-rich SC that prevents the pas-
sage of such ionised drugs at therapeutic rates. In striving to increase and also to regulate
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the permeation of drugs, a number of different methods have been explored. These can be
divided into two groups, namely active and passive. Active methods are those that use
physical means to overcome barriers, such as iontophoresis, phonophoresis and micronee-
dles [6]. Conversely, passive methods rely on the optimisation of the formulation. Such
methods include increasing the thermodynamic activity of drugs in the formulation [7],
the use of skin penetration enhancers [8] and also the use of ion pairs [9].
This review considers the research pertaining to the use of ion pairs in topical and
transdermal deliveries. As early permeation studies highlighted problems associated with
the use of rat, mouse and snake skin, such studies have been omitted [10,11]. In order
to obtain data as best aligned to human skin responses as possible, permeation data are
drawn exclusively from studies utilising human or porcine membranes [12].
2. Ion Pairs
2.1. Background
Ion pairing results when individual ions behave as a neutral species or group via
electrostatic interactions, without creating any ionic or covalent bonds [13]. In general, this
occurs most favourably in solvents with low dielectric constants (ε), as the electrostatic
interaction between ions has less competition from potential interactions with the solvent
system [14]. Ions in an aqueous environment may potentially mask their charges via
electrostatic interactions, allowing them to partition more readily into a lipid environment,
such as the SC, than individual ions [15,16].
The earliest theories concerning interactions between ions in electrolyte solutions
included Milner’s complex statistical calculation of the distribution of ions in solution,
which considered both electrostatic interaction and thermal motion. Another attempt to
calculate the energy of the interaction between ions was undertaken by Ghosh in 1918. The
author, however, assumed that ions adopted a rigid crystal-like arrangement, ignoring
the impact of thermal motion. A significant advance in the area was made by Debye
and Hückel in 1923 which proposed the interaction of a central ion (m) and other ions
in solution. The concept of an ionic atmosphere or cloud was proposed by the authors
suggesting that the relationship between the central ion and its neighbouring ions of
opposite charge was a continuum, rather than a separate interaction.
The role of electrostatic interaction between pairs of ions was first considered by
Semenchenko in 1924, but it was Bjerrum who developed the concept of ion pairs. It was
suggested that at short distances, rather than the random thermal motion of ions in the
ionic atmosphere, electrostatic interactions may develop between the central ion, m, and
an oppositely charged ion, j. These interactions are sufficiently strong to overcome the
independence of the individual ions, resulting in single-unit behaviour. When the two ions
have the same number of charges, they will be considered electrically neutral. The formula
for the total charge of two ion pairs was then devised according to Equation (1):
(zj − zm)Q0 (1)
where:
zj = charge number of the ion,
zm = charge number of the central ion, and
Q0 = elementary electric charge 1.602 × 10−19 C (C refers to the differential double layer
capacity with the units µF·cm−2).
As theorised above, the electrostatic energy of attraction between ions needs to exceed
their mean thermal energy, allowing them to draw together and attain a critical distance,
resulting in ion pair formation. As the pair is linked by electrostatic forces, but not ionic or
covalent bonds, the lifespan of the pairing, while greater than the contact of mere individual
collisions, is susceptible to collapse during strong collisions with other particles [17].
In Untersuchungen über Ionenassoziation which can be translated as “Studies of
Ion Association” [18], Bjerrum describes the activity of ions in solution using different
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solvents. The author showed how the association or disassociation of ions is dependent
on three main factors: ε of the solvent, temperature and size of the ions [19]. However,
the reliability of Bjerrum’s theory was limited, as it did not account for elements such as
solvation, concentrated solutions, solvents of high εs and hydrogen bonding [17,19–21].
Whilst extensions to the theory have been discussed [22], many of its basic principles are
still applied for the purposes of topical and transdermal drug applications.
2.2. Ion Pairs in Topical and Transdermal Drug Delivery
Partition Coefficient
The appeal of ion pairs relates to the potential for compounds that are normally soluble
in an aqueous environment, having their charges masked and enabling the partition of these
systems into a subsequent lipid environment. A simple model of ion pairing would suggest
that following passive diffusion into a lipid environment, the ion pairs would diffuse
from areas of higher concentration to areas of lower concentration. When diffusing into
an aqueous environment, the interactions with this more polar environment, comprising
a higher ε, may reduce the degree of association between the ion pair, as suggested by
Figure 1 below.
Pharmaceutics 2021, 13, 909 3 of 33 
 
 
individual collisions, is susceptible to collapse during strong collisions with other particles 
[17]. 
In Untersuchungen über Ionenassoziation which can be translated as “Studies of Ion 
Association” [18], Bjerrum describes the activity of ions in solution using different sol-
vents. The author showed how the association or disassociation of ions is dependent on 
three main factors: ε of the solvent, temperature and size of the ions [19]. However, the 
reliability of Bjerrum’s theory was limited, as it did not account for elements such as solv-
ation, conce tra ed solutions, solven s of high εs  hydrogen bonding [17,19–21]. Whilst 
extensions to the theory have been d scussed [22], m ny of its basic principle  are still 
applied for the purposes of topical and transdermal drug applications. 
2.2. Ion Pairs in Topical and Transdermal Drug Delivery 
Partition Coefficient 
The appeal of ion pairs relates to the potential for compounds that are normally sol-
uble in an aqueous environment, aving their charges masked and enabling the partition 
of these systems into a subsequent lipid environment. A simple model of ion pairing 
would suggest that following passive diffusion into a lipid environment, the ion pairs 
would diffuse from areas of higher concentration to areas of lower concentration. When 
diffusing into an aqueous environment, the interactions with this more polar environ-
ment, comprising a higher ε, may reduce the degree of association between the ion pair, 
as suggested by Figure 1 below. 
 
Figure 1. Ions in the aqueous phase moving into the lipid phase as an ion pair. 
This simple overview, however, does not account for interactions with biological 
membranes, different aqueous solubilities of compounds, solvent system combinations, 
size differences in the ion pairs and other extrinsic factors. It does, however, suggest the 
use of simple partition experiments to determine the potential of ion pairs to partition 
from aqueous into lipid environments. Such experiments have long been considered rep-
resentative of hydrophobicity, an essential component of quantitative structure–activity 
relationships (QSARs) used to predict skin permeability [23–25]. 
These tests and their results are sometimes referred to as partition coefficients, ap-
parent partition coefficients or distribution coefficients. Additionally, the logarithm of 
these values may be provided and are then referred to as Log P, Log P apparent or Log D. 
For the purposes of simplicity, this review will make reference to a partition coefficient 
(PC) or PC studies and, where possible, will include the pH at which these experiments 
were conducted. 
In general, PC measures the concentration of molecular species (S) in a non-miscible 
octanol (O) and aqueous (W) environment, as demonstrated in Equation (2), such that: PCs =  [S][S]  (2)
When incorporating factors such as pH and association or dissociation constants of 
compounds, a more representative formula for the PC of the chemical species is shown in 
Equation (3). PC  =  [𝑈] + [𝐼 ] + [𝐼 𝐼 ][𝑈] + [𝐼 ] + [𝐼 𝐼 ]  (3)
where: 𝑈 = unionised compound, 𝐼  = ionised version of the compound (anion), 
igure 1. Ions in the aqueous phase moving into the lipid phase as n ion pair.
This simple overview, however, does not account for interactions with biological
membranes, different aqueous solubilities of compounds, solvent system combinations,
size differences in the ion pairs and other extrinsic factors. It does, however, suggest the
use of simple partition experiments to determine the potential of ion pairs to partition
from aqueous into lipid environ ents. Such experiments have long been considered
representative of hydro hobicity, a essential component of quantit tive structure—activity
elationships (QSARs) used to predict skin permeability [23–25].
These tests and their results are sometimes referred to as partition coefficients, ap-
parent partition coefficients or distribution coefficients. Additionally, the logarithm of
these values may be provided and are then referred to as Log P, Log P apparent or Log D.
For the purposes of simplicity, this review will make reference to a partition coefficient
(PC) or PC studies and, where possible, will include the pH at which these experiments
were conducted.
In general, PC measures the concentration of molecular species (S) in a non-miscible





When incorporating factors such as pH and association or dissociation constants of
compounds, a more representative formula for the PC of the chemical species is shown
in Equatio (3).
PCS =
[U] + [I−] + [I− I+]O
[U] + [I−] + [I− I+]W
(3)
where:
U = unionised compound,
I−= ionised version of the compound (anion),
I+= counter ion (cation), and
I− I+= io pair.
A typical example for the descri tio of weakly acidic compound states that there
may be components of ionised, unionised and ion paired species in both the octanol
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and water phases. The same would hold for basic compounds that would use anionic
counter ions.
PC experiments were used by Inagi et al. [26] to explain how indomethacin (IND), an
acidic compound with an acid dissociation constant (pKa) of 4.5 [27], was able to permeate
to a greater extent than the predicted pH partition theory value would suggest. The PC
of IND was tested singularly, at different pH values (2.0–9.0), and in conjunction with
various cations. It was found that the PC for IND decreased from ~ 1.6 × 103 to 0.86 with
the increase in pH (2.0–9.0). However, at a pH of 8.3, the PC of IND increased (~1.6 × 101–
~1.7 × 103) with the increased concentration of sodium cations (0.02–0.10 M). Conversely,
an increase in IND concentration, while maintaining a constant concentration of sodium
cations, did not change the PC. The authors stated that this suggested the formation of
ion pair complexes between IND and sodium cations, but no association between IND
molecules. Using similar experiments, they concluded that IND was able to form ion pair
complexes with ammonium cations, potassium cations and triethanolamine [26].
PC studies have been used by many authors in advance of, or in conjunction with, ion
pair permeation studies. PC studies undertaken by Green et al. [28] indicated the ability
of the strong base naphazoline hydrochloride (HCl) to form ion pairs with fatty acids,
and these were reflected by an increase in permeation through human skin. As shown
in Table 1, the PC value for naphazoline HCl at a pH of 7.4 was 0.02 ± 0.01, increasing
to 0.36 ± 0.04 and 0.45 ± 0.06 with the addition of oleic acid (OA) and lauric acid (LA),
respectively. A PC value was reported at pH 8.0 only for neat naphazoline HCl (0.03 ± 0.01),
as the increased pH caused emulsification when fatty acids were present. The permeability
coefficients determined from the skin permeation studies, where the donor solution was
maintained at pH 8, were approximately 0.33, 2.17 and 2.58 cm h−1 × 10−3 for naphazoline
HCl, and in conjunction with OA and LA [28]. The structures of naphazoline and the fatty
acid counter ions are shown in Figure 2.
Table 1. Impact of OA and LA on the PC and permeability coefficient values for naphazoline. Concentration of naphazoline
applied was 0.05 M (n = 4, values represent the mean ± S.D.) Adapted with permission from [28], Elsevier, 1988.
Partition
Coefficient of naphazoline
Isopropyl myristate (IPM)/buffer (pH 7.4) 0.02 ± 0.01
OA in IPM/buffer (pH 7.4) 0.36 ± 0.04
LA in IPM/buffer (pH 7.4) 0.45 ± 0.06
IPM/buffer (pH 8.0) 0.03 ± 0.01
Permeability coefficient of naphazoline
using human skin
(cm h−1 × 10−3)
Naphazoline HCl ~0.33
Naphazoline plus OA ~2.17
Naphazoline plus LA ~2.58
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Figure 2. Naphazoline HCl and the counter ions LA and OA. 
Positive linear relationships were also found between experimental PC values of
lignocaine HCl (0.19, 0.40 and 6.76) and corresponding flux values (1.2 ±1.2, 13.0 ± 2.0
and 118.0 ± 30.0 µg cm−2 h−1) through human skin, as seen in Table 2 [29]. Table 3 shows
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the results of PC experiments at pH values 5.0, 6.0 and 7.0 for benzydamine HCl. These
indicate increasing PC (1.62, 5.75 and 28.18) and flux values (5.15 ± 2.42, 39.07 ± 10.50
and 269.09 ± 10.50 µg cm−2 h−1) in human skin permeation experiments as the fraction
of unionised drug increased with increasing pH (6.3 × 10−3, 0.00631 and 0.627) [30].
Megwa [31] also reported that increases in PC results for the tertiary amine counter ions
used in conjunction with salicylic acid (SA), shown in Figure 3, lead to increased permeation
in human epidermis studies as depicted in Table 4.
Table 2. PC and flux for lignocaine HCl at different donor pH values. For flux experiments, 2%
lignocaine hydrochloride was applied in buffer solutions (n = 3, values represent the mean ± S.D.)
Adapted with permission from [29], Elsevier, 2000.
pH PC (Calculated) Flux (µg cm−2 h−1)
4.0 ~0.19 1.2 ± 1.2
5.5 ~0.40 13.0 ± 2.0
7.0 ~6.76 118.0 ± 30.0
Table 3. PC, unionised fractions, permeability coefficient and flux (across human skin) for benzy-
damine HCl at different donor pH values. For flux experiments, 2% benzydamine hydrochloride
was applied in buffer solutions (n = 6, values represent the mean ± S.D.) Adapted with permission
from [30], Elsevier, 2005.
pH PC ~ Fraction Unionised PermeabilityCoefficient (cm h−1) Flux (µg cm
−2 h−1)
5.0 1.62 6.3 × 10−3 2.6 × 10−4 5.13 ± 2.42
6.0 5.75 0.0631 3.8 × 10−3 39.07 ± 10.5
7.0 28.18 0.627 6.1 × 10−2 269.09 ± 58.5Pharmaceutics 2021, 13, 909 6 of 33  
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Table 4. Effect of tertiary amines on the PC and the flux of SA through human epidermis. Donor
phase comprised equimolar concentrations of salicylate anion and amine counter ion, with actual
concentration of SA not provided by the authors; donor solvent: ethanol to propylene glycol (2:1 v/v)
(n ≥ 3, values represent the mean ± S.E.M.) Adapted from [31], Wiley, 2000.
SA with Counter Ion: PC in Octanol-Phosphate Buffer(pH 5.0)
Flux
(mg cm −2 h −1 × 10 −2)
Triethanolamine 0.007 ± 0.00 11.90 ± 1.23
Triethylamine 0.360 ± 0.00 15.40 ± 3.85
Tripropylamine 3.180 ± 0.04 18.50 ± 2.26
Tripentylamine 109.77 ± 11.37 19.50 ± 3.63
Trihexylamine 152.17 ± 26.81 22.60 ± 1.14
Trioctylamine 140.58 ± 16.33 27.90 ± 3.98
Tridodecylamine 140.66 ± 17.23 42.70 ± 2.04
In investigating the effects of counter ions on the permeation of diclofenac (DIC)
through porcine membranes, it was determined that when comparing structurally re-
lated counter ions, a higher PC often corresponded to a higher permeation coefficient, as
indicated in Table 5 below [32]. The only exception related to monoethanolamine and
monoethylamine, where the PC values of 1.2 and 1.02 resulted in permeation coefficients
of 0.70 and 2.00 cm h−1 × 103. Chemical structures of DIC and the related counter ions are
depicted in Figure 4.
Table 5. Permeation parameters of DIC salts. According to the authors, saturated solutions were
applied in permeation studies (for solubility and partition experiments, n = 3; for permeation
experiments used to calculate permeation coefficient n ≥ 5; values represent the mean) Adapted
from [32], MDPI, 2012.
DIC Plus Counter Ion: PC Solubility(µg cm−3 × 103)
Permeation Coefficient
(cm h−1 × 103)
Monoethanolamine 1.20 9.9 0.70
Monoethylamine 1.02 6.1 2.00
Diethanolamine 1.20 18.0 2.80
Diethylamine 1.48 13.7 3.70
Triethanolamine 4.37 3.4 3.00
Triethylamine 7.08 6.7 3.40
N-2-hydroxyethyl
pyrrolidine 1.48 20.2 9.60
Pyrrolidine 1.62 2.0 21.00
N-2-hydroxyethyl
piperidine 1.95 10.7 7.70
Piperidine 9.33 4.3 20.00
N-2-hydroxyethyl
morpholine 10.96 4.4 4.80
Morpholine 2.24 6.9 3.80
N-2-hydroxyethyl
piperazine 1.74 12.5 13.00
Piperazine 4.68 0.4 45.00
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PC has, however, not always correctly reflected the results of permeation studies [33].
No such correlation was found when counter ions were quaternary amines [31] or primary
amines [34]. In the latter case, PC studies for SA using octanol and water, as opposed
to isopropyl myristate (IPM) and water, toluene and propylene glycol (PG) or IPM and
PG, indicated that PC values increased when SA was combined with primary amines that
included alkyl chains longer than four carbons (as shown in Figure 5). PC values were
reported for neat solutions of SA (0.550 ± 0.104) and SA in conjunction with butylamine
(1.710 ± 0.108), pentylamine (5.170 ± 1.350), hexylamine (11.220 ± 1.014), hept la i e
( 7.950 ± 0.138), oct l i (24.340 0.658), nonylamine ( 7.160 ± 0.416), dec l i
(29.74 4.3 0), undecylamine (22.010 ± 2.344) and dodecylamine (22.680 ± 3.452). Thes
amounted to increas s in PC values of SA from a minimum of 3 to a maximum of 54 fold.
These increases in PC did not correlate with the results of human skin per eati n data in
which both flux values and perm ability coefficients were lower than thos determined
for SA (0.89 ± 1.20 mg cm−1 h−1 × 10−1 and 8.9 cm h−1 × 10−4). O e potential reason
suggested by the authors was that SA was retained in the biol gical membrane us d in
the experiments.
This was indeed the finding of Trotta et al. [35] who investigated the topical application
of retinoic acid (RA) in conjunction with he methyl and ethyl esters of various amino acids
as counter i ns shown in Figure 6. These aut ors reported a linear r lationship between
PC results and ski accumulation in full-thickness pig ear skin. PC studies measured
th partition of RA between IPM and an ethanol and pH 6.4 phosphate buffer (0.05 M)
mixture, in the absence and presence of the abovementioned counter ions. A molar ratio
of 1:50 (RA to potential counter ion) was used. The concentration of RA applied in the
permeation experiments was 0.05% w/w. PC and skin accumulation (µg cm−2) results
were presented for neat RA (1.318 × 103, 1.0 ± 0.2) and RA in conjunction with tryptophan
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methyl ester hydrochloride (1.259 × 104, 2.3 ± 0.6) phenylalanine ethyl ester hydrochloride
(3.090 × 104, 3.4 ± 0.6) and valine methyl ester hydrochloride (4.467 × 104, 3.7 ± 0.8). This
relationship did not extend absolutely to skin flux values (µg cm−2 h−1) that were reported
for RA (0.13 ± 0.02), and RA in conjunction with tryptophan methyl ester hydrochloride
(0.19 ± 0.02), phenylalanine ethyl ester hydrochloride (0.23 ± 0.03) and valine methyl ester
hydrochloride (0.21 ± 0.03), respectively. Here, the flux value for RA in conjunction with
phenylalanine ethyl ester hydrochloride (0.23 ± 0.03 µg cm−2 h−1) exceeds that for the
valine methyl ester hydrochloride (0.21 ± 0.03 µg cm−2 h−1), despite the PC results.
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Au er t al. [36] sed PC studi s to d termine whether the lipophilicity of 5-aminolevulinic
acid (ALA) could be increased by the additi n of the various counter ions depicted in
Figure 7. As ALA has two pKa values, 4.0 and 7.9, pH values of 4.0 and pH 7.0 were
mployed. Thes resulted in an anionic charge dominating at pH 7.0 and a cationic charge
domin ing at pH 4.0. Results for PC studies, as seen in Table 6, showed hat the lipophilic
shift was higher in the case of pH 7.0 wh re ALA was tested alone (1.51), or in conjunction
it t l ri i i c l ri (CP) (9.12), cetyltrimethyl-am onium bromide (8.13) and
benzalkonium chloride (6.03). In the case of pH 4.0 wher ALA was tested alone (1.20), or
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in conjunction with sodium-1-octanesulfonic acid (2.14), sodium-1-heptanesulfonic acid
(4.68) and sodium-1-pentanesulfonic acid monohydrate (2.69), the lipophilic shift was
lower. Cumulative permeation amounts of ALA through porcine skin (µg cm−2) after 4 h
showed that, with the exception of cetyltrimethylammonium bromide, all anionic and
cationic counter ions increased the cumulative permeation of ALA through porcine skin.
ALA at pH 4.0, without a counter ion, resulted in a cumulative amount of 5.11 µg cm−2.
This value increased with the addition of sodium-1-octanesulfonic acid (10.7 µg cm−2),
sodium-1-heptanesulfonic acid (10.0 µg cm−2) and sodium-1-pentanesulfonic acid mono-
hydrate (10.0 µg cm−2,) as counter ions. At pH 7.0 the cumulative amount of ALA alone
was 6.5 µg cm−2. This increased to 11.0 µg cm−2 with CP as a counter ion and 7.0 µg cm−2
when benzalkonium chloride was the counter ion. As mentioned previously, the cumulative
amount decreased with the addition of cetyltrimethylammonium bromide to 5.0 µg cm−2.
There appeared to be no correlation between cumulative permeation and PC values.




Figure 7. ALA and counter ions: sodium-1-pentanesulfonic acid, sodium-1-heptanesulfonic acid, sodium-1-octanesulfonic 
acid, cetylpyridinium chloride, cetyltrimethylammonium bromide and benzalkonium chloride. 
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mined by molecular volume or molecular weight) is also a factor recognised by QSARs as 
a contributor to increased permeability coefficients [23–25]. In spite of this, Megwa et al. 
[34] found that a longer chain length of tertiary alkylamines used as counter ions in con-
junction with salicylic acid (SA) resulted in improved permeation results through human 
skin, as shown in Table 7. Structures for these counter ions are shown in Figure 3. 
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acid, cetylpyridinium chloride, cetyltrimethylammonium bromide and benzalkonium chloride.
Table 6. PC and cumulative amount permeated of pure ALA and in conjunction with various counter ions at pH 4.0 and
pH 7.0. The concentration of ALA applied in the buffer solutions was 0.4 mg mL−1 (for permeation experiments n ≥ 3,
values represent the mean ± S.D.) Adapted with permission from [36], Els vier, 2003.
ALA Plus Counter Ion pH PC~(×10−1)
Cumulative Amount of ALA
~(µg cm−2) after 4 h Using Porcine Skin
None 4.0 1.20 5.11
Sodium-1-octanesulfonic acid 4.0 2.14 10.7
Sodium-1-heptanesulfonic acid 4.0 4.68 10.0
Sodium-1-pentanesulfonic acid monohydrate 4.0 2.69 10.0
None 7.0 1.51 6.5
Cetylpyridinium chloride 7.0 9.12 11.0
Cetyltrimethylammonium bromide 7.0 8.13 5.0
Benzalkonium chloride 7.0 6.03 7.0
In addition o use of PC stu e to test the partitioning abilities of co nter ions,
the factors described by Bjerrum as impacting their formation should not be disregarded.
These included the size or radius of the c unter ions as well as the ε of the solvent and
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temperature. A number of other areas have also been investigated in the literature such as
the impact of the type of counter ions used, the influence of pH, the quantity of counter
ions, the addition of permeation enhancers and the use of the latter as ion pairs.
2.3. Factors Influencing the Formation and Partition of Counter Ions
2.3.1. Size and Type of Counter Ion
Bjerrum indicated that the distance between centres of charge when ions are paired is
greater for large ions and smaller for smaller ions, thus potentially affecting the “cohesion”
of the ion pairs. Fini et al. [15] tested the ability of a number of inorganic ions ranging
from lithium to caesium cations to form ion pairs with the DIC anion, using PC as the
main analytical tool. With the exception of lithium, the inorganic ions sodium, potassium,
rubidium, and caesium were not as successful in forming ion pairs with the DIC anion.
An inverse correlation was indeed identified between the size of the ionic radius and the
PC. Lithium, with the smallest ionic radius, exhibited the highest PC value which reduced
with increasing ionic radius of the inorganic ions: PC of lithium > sodium > potassium >
rubidium > caesium, while the ionic radius of lithium < sodium < potassium < rubidium <
caesium [15].
In addition to the influence on potential cohesion, smaller molecular size (as deter-
mined by molecular volume or molecular weight) is also a factor recognised by QSARs as a
contributor to increased permeability coefficients [23–25]. In spite of this, Megwa et al. [34]
found that a longer chain length of tertiary alkylamines used as counter ions in conjunction
with salicylic acid (SA) resulted in improved permeation results through human skin, as
shown in Table 7. Structures for these counter ions are shown in Figure 3.
Table 7. Impact of tertiary amines on conductivity, on the permeation of SA through human epidermis, plus physicochemical
properties of tertiary counter ions (for permeation experiments n ≥ 3 ≤ 6, values represent the mean ± S.E.M.) Adapted






of Counter Ion (cm3 mol−1)
Flux
(mg cm−2 h−1) × 10−2
Conductivity
(mS cm−1)
None - - 8.90 ± 1.20 2.03 ± 0.06
Triethylamine 101.20 108.00 15.40 ± 3.85 1.77 ± 0.06
Tripropylamine 143.27 156.60 18.50 ± 2.26 1.35 ± 0.06
Tripentylamine 227.44 253.80 19.50 ± 3.63 0.90 ± 0.00
Trihexylamine 269.52 302.40 22.60 ± 1.14 0.80 ± 0.00
Trioctylamine 353.68 399.60 27.90 ± 3.98 0.60 ± 0.00
Tridodecylamine 522.00 592.50 42.70 ± 2.04 0.30 ± 0.00
The authors attributed this to the increase in lipophilicity as the alkyl chain length
increased. It should also be noted that the highest molecular mass of any of the counter ions
was 522 Da. While this did not appear to conform with the aforementioned rules relating
to molecular size, it did result in the highest flux value. The same study also examined
the effect of quaternary ammonium compounds on the permeation of SA and found that
these did not impact the overall permeation of the active ingredient. It was determined
that amine counter ions affect permeation through the human epidermis in the following
sequence: quaternary < primary < secondary < tertiary.
The previously discussed Auner study [36] also examined the efficacy of various
quaternary ammonium compounds as counter ions for ALA. As was noted, and can be seen
in Table 6, these yielded diverse flux results in permeation tests using porcine skin. When
paired with cetyltrimethylammonium bromide, despite having higher PC values than neat
ALA (~8.13 × 10−1 in contrast to ~1.51 × 10−1), it was reported to have a cumulative
permeation of approximately 5 µg cm−2 after 4 h, while the flux of ALA without the
counter ion was approximately ~6.5 µg cm−2 for the same period. Benzalkonium chloride
(PC value of ~6.03 × 10−1) and CP (PC value of ~9.12 × 10−1) did improve the cumulative
flux values with results of approximately 7 and 11 µg cm−2, respectively, after 4 h [36]. A
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number of reasons for the permeation results were suggested by the authors, in accordance
with studies by Takacs-Novak and Szasz [37] that examined the partition of quaternary
ammonium substances. These included the influence of lipophilicity, size and flexibility,
expressed as the number of rotating carbon-carbon sigma bonds, of the counter ions. Whilst
it was mentioned that no significant effect had been attributed to the type (such as aliphatic
or aromatic) of quaternary nitrogen compound, much importance was attributed to the
lipophilicity and association constants of ion pairs, emphasising the necessity of attaining
a critical separation distance, without which ion pairs cannot be formed.
The same study also tested the use of sulfonic acid sodium salts as counter ions in
conjunction with ALA (Table 6). While there was an increase in the cumulative permeation
of ALA at pH 4.0 from ~5.11 µg cm−2 h−1 when counter ions were added, there was no
significant difference in the cumulative permeation amounts of the different counter ions.
The use of sodium-1-octanesulfonic acid resulted in the highest cumulative permeation at
~10.7 µg cm−2 h−1, while sodium-1-heptanesulfonic acid and sodium-1-pentanesulfonic
acid monohydrate both had cumulative permeation results of ~10.0 µg cm−2 h−1.
PC investigations indicated that organic cations were more successful than inorganic
cations when forming ion pairs with the DIC anion [15]. It was suggested that when a salt
contains both an organic anion and cation, some of the hydrophobic character remains.
This was described by Minghetti and co-workers who considered the impact of four salts
used in pharmaceutical applications in conjunction with DIC on the permeation of the latter
through human skin. The salts were described as sodium, potassium, diethylamine and
epolamine (N-(2-hydroxyethyl)pyrrolidine), the structures of which can be see in Figure 8.
The findings suggested that associating an organic cation, such as the diethylamine and
epolamine, and an organic anion in pharmaceutical salts guarantees improved perme-
ation results. These results are contained in Table 10, showing the flux values for DIC
(µg cm−2 h−1) in conjunction with the inorganic counter ions sodium (2.29 ± 0.37) and
potassium 1.35 ± 0.72 increase with the organic counter ions diethylamine (5.60 ± 2.14)
and epolamine (2.90 ± 0.91), when using water as a solvent [38].
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counter ions, benzoate (Bz) and oleate (Ol), were also considered by Cilurzo
and co-workers [33] for the pairing of a chiral com ound, pr pranolol (PR), as a race-
mate, RS-PR, and as a single enantiomer, S-PR (Figure 9 and Table 8). Despite partition
studies reflecting a 78% increase in the PC value for RS-PR as well as an 104% increase
for S-PR, when tested with the Ol counter ion, permeation data showed drug fluxes
reducing in conjunction with the counter ion. The flux of the racemate in saline re-
duced from 18.0 ± 5.1 µg cm−2 h−1 to 7.0 ± 1.4 µg cm−2 h−1 when combined with Ol.
The flux of the racemate in mineral oil (MO) decreased from 24.2 ± 4.7 µg cm−2 h−1 to
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7.3 ± 1.4 µg cm−2 h−1 when combined with Ol. The S-enantiomeric form of PR showed
higher flux results than the racemate when applied neat, whether in saline
(44.7 ± 5.1 µg cm−2 h−1) or MO (41.9 ± 1.5 µg cm−2h−1). When Ol was used as a counter
ion, the flux of the S-enantiomer plummeted to 6.2 ± 0.9 µg cm−2 h−1 when in saline and
to 11.1 ± 1.7 µg cm−2 h−1 when in MO. When Bz was used as the counter ion, it increased
the PCs of the racemate and the S-enantiomer marginally, from 10.00 and 9.33 to 11.74
and 11.48, respectively. This again failed to translate into an increase in the flux from
saline for both the racemate (18.0 ± 5.1 to 1.7 ± 0.2 µg cm−2 h−1) and the S-enantiomer
(44.7 ± 5.1 to 3.0 ± 0.4 µg cm−2 h−1). The situation was repeated when Bz was used as
the counter ion with MO was the solvent. The flux for RS-PR reduced from 24.2 ± 4.7 to
1.6 ± 0.3 µg cm−2h−1 and for S-PR from 41.9 ± 1.5 to 2.9 ± 0.7 µg cm−2 h−1 [33].
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In 2012, Fini et al. [32] considered the ability of DIC salts in aqueous solutions to 
permeate through porcine membranes. The choice of counter ions (Figure 4) included al-
iphatic alkyl amines: mono, di and tri ethyl amines, which were contrasted with mono, di 
and tri ethanol amines. Examples also included a range of cyclic substituents: pyrrolidine, 
piperidine, piperazine and morpholine. These were contrasted with structurally similar 
molecules that included hydroxy ethyl side chains, namely N-(2-hydroxyethyl) pyrroli-
dine, N-(2-hydroxyethyl) piperidine, N-(2-hydroxyethyl) piperazine and N-(2-hydroxy-
ethyl) morpholine. The solutions used in these studies were saturated, which made the 
comparison of flux values challenging. Instead, flux was divided by solubility (in µg/cm3) 
in order to obtain a permeability coefficient. When comparing structurally related pairs of 
salts (Table 5), the authors ascertained that the results suggested “that a common mecha-
nism associated with permeation is the hydrophobicity of the permeant species”. In most 
cases, the salt which contained the hydroxy group showed a higher aqueous solubility 
(when compared to the paired ion that did not contain the same hydroxy substituent), but 
this generally did not translate into a higher permeation coefficient. Counter ions pyrrol-
idine, piperidine and piperazine resulted in increased permeation coefficients when com-
pared to their related counter ions containing hydroxy groups. Morpholine counter ions 
showed an affinity for the aqueous phase which reduced permeation when compared to 
other cyclic related salts. 
The impact of one and two double bonds on an 18-carbon fatty acid counter ion on 
the flux of physostigmine (PHY) through porcine skin, was described in 2005 by Wang 
[39]. OA (C18:1) and linoleic acid (C18:2), whose structures can be seen in Figure 10, re-
sulted in PC values for PHY, between IPM and PG, of 0.225 ± 0.035 and 0.219 ± 0.01, re-
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(RS)-PR 10.00 0.189 18.0 ± 5.1 1.321 24.2 ± 4.7
(S)-PR 9.33 0.432 44.7 ± 5.1 3.111 41.9 ± 1.5
(RS)-PR-Bz 11.74 4.430 1.7 ± 0.2 0.065 1.6 ± 0.3
(S)-PR Bz 11.48 9.560 3.0 ± 0.4 0.118 2.9 ± 0.7
(RS)-PR-Ol 17.78 0.020 7.0 ± 1.4 3.930 7.3 ± 1.4
(S)-PR-Ol 19.05 0.020 6.2 ± 0.9 5.874 11.1 ± 1.7
In 2012, Fini et al. [32] considered the ability of DIC salts in aqueous solutions to
permeate through porcine membranes. The choice of counter ions (Figure 4) included
aliphatic alkyl amines: mono, di and tri ethyl amines, which were contrasted with mono, di
and tri ethanol amines. Examples also included a range of cyclic substituents: pyrrolidine,
piperidine, piperazine and morpholine. These were contrasted with structurally similar
molecules that included hydroxy ethyl side chains, namely N-(2-hydroxyethyl) pyrrolidine,
N-(2-hydroxyethyl) piperidine, N-(2-hydroxyethyl) piperazine and N-(2-hydroxyethyl)
morpholine. The solutions used in these studies were saturated, which made the compari-
son of flux values challenging. Instead, flux was divided by solubility (in µg/cm3) in order
to obtain a permeability coefficient. When comparing structurally related pairs of salts
(Table 5), the authors ascertained that the results suggested “that a common mechanism
associated with permeation is the hydrophobicity of the permeant species”. In most cases,
the salt which contained the hydroxy group showed a higher aqueous solubility (when
compared to the paired ion that did not contain the same hydroxy substituent), but this
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generally did not translate into a higher permeation coefficient. Counter ions pyrrolidine,
piperidine and piperazine resulted in increased permeation coefficients when compared to
their related counter ions containing hydroxy groups. Morpholine counter ions showed an
affinity for the aqueous phase which reduced permeation when compared to other cyclic
related salts.
The impact of one and two double bonds on an 18-carbon fatty acid counter ion on
the flux of physostigmine (PHY) through porcine skin, was described in 2005 by Wang [39].
OA (C18:1) and linoleic acid (C18:2), whose structures can be seen in Figure 10, resulted
in PC values for PHY, between IPM and PG, of 0.225 ± 0.035 and 0.219 ± 0.01, respec-
tively. Flux values were 19.7 ± 8.2 µg cm−2 h−1 for the counter ion C18:1 and only
2.4 ± 0.9 µg cm−2 h−1 when the counter ion was C18:2, despite solubility for the two being
very similar (83.9 mg mL−1 for C18:1 and 85.3 mg mL−1 for C18:2). The authors suggested
that the presence of the additional unsaturation may have caused the retention of the
complexes in the SC lipids [39]. Conversely, the effect of a single unsaturation on the OA
structure was also mentioned by Green et al. [28] as a potential reason for making this a
better permeation enhancer than LA, a 12-carbon saturated fatty acid.
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e tral sol tions. Sol tions co prising a 4% weight of carnitine, alone and in equimolar
ratios with betaine, polyquaterium-51 or hydrogenated soya phosphatidylcholine (HSC),
were used for permeation experiments. When combined with the active in solution, betaine
and polyquaterium-51 reduced carnitine’s percutaneous penetration, while the combination
with hydrogenated soya phosphatidylcholine (HSC), a higher-molecular-mass (762.1 Da)
long-chain-carbon structure, nearly tripled it. The percentage of applied carnitine found in
epidermal layers of porcine skin after 24 h was approximately 9.13% when carnitine was
applied without any counter ion, 4.25% when applied with betaine, 6.55% when applied
with polyquaterium-51 and 23.71% when applied with HSC [40].
2.3.2. Dielectric Constant (ε)
In 1956, Kraus [19] tested components of Bjerrum’s theory, including the relationship
between the dissociation of ion pairs to the ε of the solvent. Using water–dioxane mixtures
as the solvent system and the salt tetraisoamylammonium nitrate, it was found that for
values of ε greater than 44, ions were dissociated. Tetrabutylammonium bromide and
sodium bromate were found to be dissociated for values of ε above 50. Irrespective of
whether aqueous or organic solvents were used, there was a clear relationship between a
higher ε reducing the association between ion pairs, and a lower ε increasing the association
between ion pairs.
Pharmaceutics 2021, 13, 909 14 of 31
Pharmaceutics 2021, 13, 909 14 of 33 
 
 
0.9 µg cm−2 h−1 when the counter ion was C18:2, despite solubility for the two being very 
similar (83.9 mg mL−1 for C18:1 and 85.3 mg mL−1 for C18:2). The authors suggested that 
the presence of the additional unsaturation may have caused the retention of the com-
plexes in the SC lipids [39]. Conversely, the effect of a single unsaturation on the OA struc-
ture was also mentioned by Green et al. [28] as a potential reason for making this a better 
permeation enhancer than LA, a 12-carbon saturated fatty acid. 
 
Figure 10. Physostigmine and counter ions OA and LA. 
More recently in 2019, In and co-workers [40] tested three different zwitterions in 
conjunction with carnitine Figure 11, which prevails as a zwitterion in weakly acidic or 
neutral pH solutions. Solutions comprising a 4% weight of carnitine, alone and in equimo-
lar ratios with betaine, polyquaterium-51 or hydrogenated soya phosphatidylcholine 
(HSC), were used for permeation experiments. When combined with the active in solu-
tion, betaine and polyquaterium-51 reduced carnitine’s percutaneous penetration, while 
the combination with hydrogenated soya phosphatidylcholine (HSC), a higher-molecu-
lar-mass (762.1 Da) long-chain-carbon structure, nearly tripled it. The percentage of ap-
plied carnitine found in epidermal layers of porcine skin after 24 h was approximately 
9.13% when carnitine was applied without any counter ion, 4.25% when applied with be-
taine, 6.55% when applied with polyquaterium-51 and 23.71% when applied with HSC 
[40]. 
 


















i r . ar iti e it iff r t i i i : t i , l t i .
The impact of solvents with different ε values may be tested by determining the
conductivity of the ions in solution. The higher the quantity of ions in solution, the
higher the conductivity. As ion pairing increases, charges become masked or neutralised,
resulting in lower conductivity results [14]. The use of conductivity measurements can
therefore be an important tool to test the impact of solvent adjustments on the formation
of ion pairs. By increasing the proportion of a particular solvent with a lower ε, columbic
interactions between the oppositely charged ions of the potential ion pairs may become
more stable, resulting in the formation or stabilisation of ion pairs, and thus potentially
facilitating partition.
In the early 1990s, Pardo et al. [41] tested IPM, isopropyl alcohol (IPA) and various
mixtures of both solvents to determine the impact of solvent adjustment on the permeation of
counter ions PHY and salicylate (Figure 12) without the use of conductivity measurements.
IPA’s ε, 18.62 at 20 ◦C [42,43], was far higher than the value determined for IPM, 3.31 at
25 ◦C [44]. Nonetheless, it was still only approximately one-quarter of the value of the ε of
water, determined to be 80.37 at 20 ◦C [43]. As seen in Table 9, it was found that a solvent mix-
ture comprising a 70:30 ratio of IPA to IPM had the best impact on permeation. Flux of PHY
increased from 0.56 ± 0.08 × 104 µmol cm−2 m−1 at its lowest rate determined when the
solvent comprised 100% of IPA, to 44.27 ± 9.16 × 104 µmol cm−2 m−1 when the solvent mix-
ture contained 70% IPA. Flux of salicylate increased from 1.47 ± 0.11 × 104 µmol cm−2 m−1
at its lowest rate, which occurred when the solvent comprised 100% IPM to
61.66 ± 2.54 µmol cm−2 m−1 when the proportion of IPM was reduced to 30%.
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Table 9. Flux values for PHY and salicylate through excised human skin, which according to the
authors, were delivered from equimolar saturated solutions of solvents consisting of IPA, IPM and
their mixtures (n ≥ 3 ≤ 8, values represent the mean ± S.E.M.) Adapted from [41], Wiley, 1992.
Volume Fraction of IPA in IPA-IPM
Solvent Mixture Flux × 10
4 µmol cm−2 m−1
PHY Salicylate
0 1.28 ± 0.35 1.47 ± 0.11
0.1 5.75 ± 0.58 6.3 ± 0.50
0.3 14.55 ± 0.71 18.2 ± 0.56
0.5 31.70 ± 3.10 47.8 ± 11.50
0.7 44.27 ± 9.16 61.66 ± 2.54
0.9 5.52 ± 0.28 17.70 ± 1.90
1 0.56 ± 0.08 1.87 ± 0.10
In early 2000, Megwa et al. [31] took a different approach. Instead of measuring the
impact of different solvents on the conductivity of ions, the authors tested the conductivity
of SA alone and in conjunction with a variety of potential counter ions in a fixed ethanol-
propylene glycol (2:1 v/v) solvent combination in equimolar concentrations. As shown in
Table 7, when the counter ions were tertiary amines, the conductivity of SA diminished
with each consecutive increase in the length of the carbon chain of the counter ion. A
relationship could be seen between the length of the carbon chain of the tertiary amine,
conductivity, PC and flux: longer carbon chains resulted in lower conductivity, which
generally represented higher PC values and higher flux, as seen in Table 4. However, this
was limited to tertiary amines. The relationship did not extend to quaternary or primary
amines [34],where, in the latter, there was very little difference in conductivity between
neat SA or in conjunction with counter ions.
Four individual single solvents were tested with the inclusion of four different counter
ions in conjunction with DIC by Minghetti et al. [38]. The solvents included water, PG,
Transcutol® (TC) and OA. The solubility of the drug which included its associated counter
ion was generally much higher with TC and OA, yet flux values were greater when
water and OA were used (Table 10). This research highlighted a key factor in ion pairing
formulation, namely that high concentration of the drug does not guarantee an increase
in flux values. The authors determined that the solubility parameters of the salts, as well
as the solvents, TC and PG, were all comparable. They stated that “small differences in
solubility parameters of a drug and its vehicle do not cause extensive partitioning of the
drug out of its vehicle”. Unsurprisingly the flux values measured in TC and PG were the
lowest among the four vehicles for all the four salts, as “the lower the tendency of the
solute to leave the donor phase, the lower the flux.” These similar solubility parameters
indicated that the solute might be more likely to be soluble in these solvents, but less likely
to partition out of the vehicle. The authors concluded that permeability in permeation
studies comprised two distinct features: firstly, the solubility of the solute in the donor
phase and, secondly, the ability to partition out of the formulation and into the membrane.
Table 10. Impact of different solvents on the solubility and flux of DIC in conjunction with different salts as counter ions.
According to the authors, saturated solutions of the DIC salts were applied for permeation experiments (n = 3, values
represent the mean ± S.D.) Adapted with permission from [38], Elsevier, 2007.
DIC Plus Counter Ion Parameter
Solvents
Water PG TC® OA
Sodium
Solubility
(µg mL−1) 37 ± 10 567 ± 31 660 ± 70 25 ± 10
Flux
(µg cm−2 h−1) 2.29 ± 0.37 1.21 ± 0.06 0.06 ± 0.01 1.84 ± 0.18
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Table 10. Cont.
DIC Plus Counter Ion Parameter
Solvents
Water PG TC® OA
Potassium
Solubility
(µg mL−1) 218 ± 80 898 ± 79 709 ± 52 60 ± 50
Flux
(µg cm−2 h−1) 1.35 ± 0.72 0.04 ± 0.02 0.84 ± 0.06 1.17 ± 0.17
Diethylamine
Solubility
(µg mL−1) 19 ± 10 384 ± 14 279 ± 10 63 ± 60
Flux
(µg cm−2 h−1) 5.60 ± 2.14 0.35 ± 0.04 0.96 ± 0.59 2.74 ± 0.94
Epolamine
Solubility
(µg mL−1) 557 ±15 637 ± 60 430 ± 0.00 94 ± 70
Flux
(µg cm−2 h−1) 2.90 ± 0.91 0.46 ± 0.21 0.03 ± 0.00 3.11 ± 0.18
In 2005, Wang and co-workers [39] investigated the impact of two single solvents, PG
and mineral oil (MO), on the permeation of PHY in conjunction with fatty acid counter ions
in porcine skin (Table 11). Conductivity measurements were undertaken in a manner simi-
lar to those employed by the Megwa [31] study mentioned above. The conductivity of PHY
was tested alone and then in combination with a series of fatty acids of increasing carbon
chain length in PG and then in MO. The main difference between the two studies was that
the concentration of fatty acid: drug mixtures had a molar ratio of 50:1. Notwithstanding a
low conductivity value for PHY in PG when tested in isolation, testing revealed a decrease
in the conductivity of the PHY–counter ion solution, with an increase in the alkyl chain
length of the fatty acid counter ion. These results for PHY unmixed and then combined
with fatty acid counter ions of carbon chain lengths: 2, 3, 8, 10, 12, 18:1 and 18:2 were ~0.25,
16, 14, 10, 9.5, 8, 3 and 4 µS cm−1. Conductivity results were extremely low when conducted
in MO. PHY alone in MO resulted in a conductivity value of ~9.25 × 10−2 µS cm−1 and
never increased beyond ~9.4 × 10−2 µS cm−1 when combined with counter ions. The lack
of any significant change in the conductivity of MO containing fatty acids when PHY was
added, suggested to the authors that no ionisation of the PHY occurred, leading to an
absence of ion pairing in this solvent system. Flux results were determined for saturated
solutions of MO and PG. The counter ion with the longest carbon chain, OA (C18:1), con-
sistently showed the best flux values in both solvents, 19.7 ± 8.2 µg cm−2 h−1 in PG and
13.9 ± 7.1 µg cm−2 h−1 in MO, as shown in Table 11. PHY together with the OA counter
ion was greater than 5-fold more soluble in PG (83.9 mg mL−1) than in MO (15.9 mg mL−1).
However, flux was only 1.4-fold greater. The lag time for the MO vehicle was ± 4.8 h
whereas PG was shown to be ± 8.8 h.
Partitioning of PHY from PG was subsequently explained by the authors based on
two factors. Firstly, the ion pairing that resulted in the reduced polar environment and
secondly the impact of increasing lipophilicity due to the increased carbon chain length
of the counter ion. Where ion pairs were formed with short chain fatty acids, these were
described as strong ion pairs, due to a higher polarity of the counter ions. The longer the
alkyl chain, the weaker the ion pairing, but the more lipophilic the nature of the ion pair.
A more stable ion pair was noted to have lower lipophilicity than a more unstable one,
making partitioning less likely. The authors also raised the importance of concentration
as a driving force for drug diffusion as well as the impact of the solvent’s contribution to
improving the partitioning of the drug into the skin.
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Table 11. Flux, conductivity (Con) and solubility (Sol) of PHY in PG and MO. According to the authors, saturated drug
solutions were used in permeation experiments. Fatty acid counter ions are indicated according to length of carbon chain.
18:1 (OA, 1 double bond) and 18:2 (LA, 2 double bonds) (for conductivity and permeation experiments n = 3, values


















None - 0.25 71.0 2.5 ± 0.7 9.25 1.7
2 - 16 - - 9.45 -
3 - 14 - - 8.65 -
8 - 10 116.0 3.2 ± 0.6 9.05 5.1
10 - 9.5 80.7 6.6 ± 2.3 9.40 10.8
12 0.2 ± 0.0 8 88.7 14.0 ± 3.0 8.95 15.3
18:1 19.7 ± 8.2 3 83.9 13.9 ± 7.1 8.80 15.9
18:2 2.4 ± 0.9 4 85.3 3.9 ± 1.1 9.15 15.7
As shown in Table 8, MO and a saline solution were used as potential solvents when
using PR as a racemic mixture or in its S-enantiomeric form, in conjunction with counter
ions. PC values increased due to ion pairing with Ol, from 10.00 and 9.33 for (RS)-PR
and (S)-PR without Ol to 17.78 and 19.05 with Ol. Solubility also increased in MO from
1.321 and 3.111 mg mL−1 for (RS)-PR and (S)-PR without Ol to 3.930 and 5.874 mg mL−1
with Ol. Despite the increased PC and solubility values, when MO was used as the donor
solvent in permeation experiments, flux values were comparatively low (7.3 ± 1.4 and
11.1 ± 1.7 µg cm−2 h−1 for (RS)-PR and (S)-PR in combination with Ol, versus 24.2 ± 4.7
and 41.9 ± 1.5 for (RS)-PR and (S)-PR without the counter ion). The authors concluded that
this could be due to the stabilisation of the solute in the donor phase [33].
More recently, in 2019, conductivity was used in a novel fashion by In et al. [40], to
determine the optimal molar ratio of zwitterionic ion pairs, with the lowest conductivity
occurring at approximately a 1:1 ratio for the chosen counter ion. This resulted in an
extension of previous approaches which considered the impact of the dielectric constants
of solvents on the conductivity of ions in solution, or the impact on conductivity of using
different counter ions.
2.3.3. Temperature
Another factor introduced by Bjerrum in the late 1920s was the impact of temperature
on ion pairing. In the paper “Evolution of the Ion-Pair Concept”, Kraus [19] explained that
for solvents of a high ε value an increase in temperature caused an increase in ion pairing,
whilst the converse is true for solvents with a low ε. Conductance measurements were used
by Kraus as one possible method to demonstrate the increase in ion association in solvents
of higher εs, with increasing temperature. The author showed that for solutions using
solvents with a ε greater than ~10, and with a concentration range between 0.1 and 0.01
N the conductance values increase with increasing temperatures as a result of decreasing
viscosity. As shown in Table 12, as temperature increases, the conductance increases at a
decreasing rate. The conductance value reaches a maximum and then begins to decrease.
In addition, from Table 13, it is evident that the lower the ε, the lower the temperature
of the conductance maximum, for a given concentration. Methylamine, ammonia and
methanol have ε values of 9.4 at 25 ◦C, 22.4 at ~33.3 ◦C and 32.8 at 25 ◦C. Methylamine with
the lowest ε has a conductance maximum at 15 ◦C. Ammonia, with a ε value approximately
midway between methylamine and methanol, has its conductance maximum at 25 ◦C.
Finally, methanol, with the highest ε of the three solvents, has a conductance maximum
at 150 ◦C.
The author explained that as temperature rises, ion association increases until the
decrease in conductivity, due to the ion association, just offsets the increase in conductivity,
attributable to increasing fluidity, at the temperature of maximum conductance. From this
temperature, ion association continues to increase and conductance to decrease. As the
concentration of the solution is subject to very little variance due to changes in temperature
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under the specified conditions, the conductance provides a guide to the increasing associa-
tion attributable to increasing temperature. It was further noted that the actual extent of ion
association is greater than indicated by the conductivity measurements, as the fluidity of
the solution increases with the temperature, causing the conductance values to be greater
than expected.
Table 12. Conductance of potassium iodide in methanol at different temperatures. Units were not
provided, but the trend in overall values may be used to demonstrate the concepts. Adapted from [19],
American Chemical Society, 1956. The bold indicates the temperature of maximum conductance.
~Temperature ◦C ~Conductance
80 500 × 106
100 576 × 106
120 638 × 106
150 700 × 106
180 654 × 106
200 577 × 106
220 400 × 106
240 14.2 × 10−2
Table 13. The temperature at which the highest conductance value is reached for potassium iodide in
solvents of different ε values: methylamine, ammonia and methanol. Adapted from [19] American
Chemical Society, 1956.
Solvent ε Conductance Maximum Reached at ◦C
Methylamine 9.4 at 25 ◦C 15
Ammonia 22.4 at ~33.3 ◦C 25
Methanol 32.8 at 25 ◦C 150
2.3.4. pH
As previously mentioned, pH modification in given solvent systems introduces
changes to PC values. In this section, some of the concepts formerly mentioned will
be revisited for the purpose of clarity and contextualisation of theory.
The pH partition theory suggests that only unionised drugs can permeate lipid mem-
branes, whilst ion pairing attempts to achieve this via the masking of charges. In order
to optimise partition and permeation of several molecular compounds, pH has been in-
vestigated in various respects. An example of this is the exploration of the slightly acidic
pH values long attributed to the surface of the skin [45], and the physiological pH values
associated with the lower layers of this biological membrane. Hadgraft et al. [46] tested
whether such a pH gradient could be used to ionise the participating compounds, sodium
salicylate and Ethomeen S12 (N,N-bis(2-hydroxyethyl)oleylamine), enabling the formation
of ion pairs between the two. The purpose was to facilitate the transport of the active
ingredient, salicylate, through the skin. Whilst this increased the transport of salicylate by
approximately 3 fold when using a preparatory artificial lipid membrane and did not affect
the control compound, caffeine (a weakly basic drug that was cationic at the pH values
examined), the results could not be replicated when using human skin. Instead, the counter
ion, Ethomeen S12, improved the transport of both salicylate and caffeine, suggesting an
interference with the skin barrier.
The aforementioned studies by Green et al. [28] also involved the manipulation of pH.
The purpose of such experiments was to facilitate the transfer of cations across human skin
using ionised OA and LA as counter ions. In this study, however, the pH of the donor phase
solution used in permeation experiments was higher than that of the receptor solution and
also exceeded the pKa of both LA and OA. The drug was basic in nature and ionised at the
donor’s pH environment. Though the counter ions, LA and OA, increased the in vitro skin
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permeation of all the permeants, it was concluded by the authors that the increased flux of
the cationic naphazoline could be partly attributed to ion pairing.
Valenta and co-workers’ research in the late 1990s [29] considered the permeation of lig-
nocaine hydrochloride in human skin. These authors used a range of donor solutions with
different pH values: 4.0, 5.5 and 7.0, intended to reflect various physiological conditions.
As shown in Table 2, the flux was 1.2 ± 1.2 µg cm−2 h−1 at pH 4.0, 13.0 ± 2.0 µg cm−2 h−1
at pH 5.5 and 118.0 ± 30.0 µg cm−2 h−1 at pH 7.0. PC values of the lignocaine salt were
0.19 at pH 4.0, 0.40 at pH 5.5 and 6.76 at pH 7.0, both increasing with higher pH values.
This was due to the increase in the amount of unionised base, consistent with the pH
partition hypothesis.
Megwa and co-workers [34] demonstrated a procedure for determining the optimum
pH conditions for ion pair formation between SA and various amines. The system em-
ployed was very similar to a typical PC study, with the use of toluene instead of octanol as
the lipid phase, and a range of pH buffers (pH 2.5–7.5) as the aqueous phase. Following a
comparable approach to that of Green [28], the drug was dissolved in the aqueous buffers
and the counter ions added to the lipid phase, as opposed to dissolving the potential
counter ions in the aqueous phase only. The optimal pH for the formation of ion pairs
with the amines used (methylamine, ethylamine, propylamine, butylamine, diethylamine,
triethylamine and triethanolamine) was ascertained to be pH 5.0.
Further studies involving SA were also undertaken by Smith and Irwin [47] in the
same year. The authors tested both solutions and saturated suspensions of SA over a range
of pH values. As hypothesised, experiments showed that the flux of SA across human
skin from solutions was dependent on the pH of the vehicle (Table 14). The authors also
determined that the flux from saturated suspensions across human skin remained relatively
constant throughout the experiments (mean flux 1.09 ± 0.202 µmol cm−2 h−1) regardless
of the different pH values (pH 1.84, 2.35, 2.80, 3.14, 3.45, 3.73, 4.17, 4.71). This confirmed
that permeation is related to the concentration of unionised molecules, and is independent
of pH or pH gradients (when a saturated suspension is used). Furthermore, this study
demonstrated that the solubility of unionised SA in a suspension remained constant at
different pH values, indicating a method of overcoming the impact of pH on solubility and
maintaining maximum solubility [47].
Table 14. Flux ± standard deviation of 14.48 mM solutions of SA across human skin at a range of pH
values (experiments n = 2, values represent the mean ± S.E.) Adapted with permission from [47],
Elsevier, 2000.
pH Flux (µmol cm−2 h−1)
2.10 0.72 ± 0.057
2.27 0.59 ± 0.016
2.72 0.54 ± 0.009
3.13 0.25 ± 0.006
3.50 0.15 ± 0.005
3.90 0.07 ± 0.001
4.30 0.05 ± 0.001
4.71 0.04 ± 0.000
5.13 0.01 ± 0.000
A previously mentioned study by Auner et al. [36] involved devising optimal pH
values for ion pairing which enabled the testing of both cationic (pH 7.0) and anionic (pH
4.0) counter ions in conjunction with ALA, a molecule that comprises two pKa values (4.0
for the carbonyl group and 7.9 for the amino group). Analysis using PC studies indicated
increased lipophilicity when ALA was combined with any of the counter ions. Higher
lipophilicity resulted in increased permeation through porcine skin with all counter ions,
with the exception of cetyltrimethylammonium bromide, as shown in Table 6.
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A study by Sarveiya et al. [30] also tested the influence of donor compartment pH
values in permeation experiments on the ionisation, partitioning and flux of benzydamine
HCl, as seen in Table 3. In human skin studies, the authors found that as the PC in-
creased with an increase in pH, so did the flux. At pH 5.0 PC value was 1.62 and flux
5.13 ± 2.42 µg cm−2 h−1; at pH 6.0 PC value was 5.75 and flux 39.07 ± 10.5 µg cm−2 h−1
and at pH 7.0 PC value was 28.18 and flux 269.09 ± 58.5 µg cm−2 h−1. The authors did
suggest, however, that as the pH increased beyond these values, although the unionised
fraction and the permeability coefficient would increase too, flux would be limited due to
decreasing solubility.
In research by Cázares-Delgadillo [48] that investigated the impact of sucrose esters on
the permeation of lidocaine HCl (see Figure 13) using porcine skin, both PC and permeation
experiments were considered at pH values 5.0, 7.0 and 9.0. The fraction of unionised species
was derived from the Henderson–Hasselbalch equation, and it was determined that at pH
5.0 lidocaine was completely ionised, at pH 7.0, 11% was unionised and at pH 9.0, 93% was
unionised. The PC studies reflected this, with higher values attributed as pH increased
(0.09 ± 0.002 at pH 5.0, 1.15 ± 0.007 at pH 7.0 and 1.17 ± 0.0043 for pH 9.0). Permeation
of lidocaine alone also increased when the pH value of the buffered solution increased.
As all solutions were saturated, permeability coefficients were obtained by dividing the
flux by the concentration of the drug in the applied formulation. As shown in Table 15,
permeability coefficients increased as pH increased. Apparent permeability coefficients for
different pH values of lidocaine HCl and in the presence of sucrose laureate (L-TC) and
sucrose oleate (O-TC) are also shown in Table 15. It was determined that pre-treatment
of the porcine ear membranes with L-TC or O-TC in Transcutol® had a surprising impact
on flux, permeation coefficients and overall enhancement, as results deviated from those
expected due to the abovementioned pH partition hypothesis. At pH 5.0 and pH 7.0, (where
100% and 89%, respectively, of lidocaine was ionised) L-TC enhanced the permeability
coefficient of lidocaine alone by 11.95 and 10.84 fold. At pH 9.0, where lidocaine was 100%
unionised, the presence of L-TC reduced the permeability coefficient to 59% of lidocaine
HCl. Conversely, the application of O-TC (while increasing the permeability coefficient by
3.77 and 3.45 fold of that of lidocaine alone at pH values 5.0 and 7.0, respectively) led to an
improvement in the permeability coefficient of the unionised lidocaine by 2.67 fold at pH
9.0. Investigations by the same group also indicated that L-TC causes lipid extraction and
fluidisation of the skin barrier, creating structural disorder and an increase in micropores
in the membrane which may facilitate greater penetration of the ions. The authors were,
however, unable to rationalise the decreased movement of unionised lidocaine through
the biological membrane. Whilst this may indeed suggest the formation of ion pairs at pH
values at which lidocaine is ionised, the authors considered this option unlikely [48].
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Table 15. Apparent permeability coefficients for different pH values for lidocaine HCl and in the presence of L-TC and O-TC.
According to the authors, saturated solutions of lidocaine were used (n = 6, values represent the mean ± S.D.) Adapted
with permission from [48], Elsevier, 2005.
pH







5.0 1.55 ± 0.31 18.46 ± 5.60 5.83 ± 0.65
7.0 1.81 ± 1.1 19.58 ± 3.82 6.24 ± 0.31
9.0 5.65 ± 1.52 3.34 ± 0.22 15.08 ± 2.30
In 2005, Wang et al. [39] attempted to measure pH values of fatty acids in PG and de-
termined that shorter chain fatty acids had lower pH levels in this solvent. The authors also
found that the addition of PHY increased the pH values of given formulations, suggesting
neutralisation of the acid, and thus ion pairing (values not disclosed by the authors).
Vávrová and co-workers’ study in 2008 described the complex molecular structures
of adefovir and its proposed counter ion, 6-(dimethylamino)hexanoate (DDAK), that had
previously been used by this group as a permeation enhancer (Figure 14). The authors
tested the permeation of the adefovir ion pair through porcine skin using phosphate buffer
solutions. These solutions were adjusted using phosphoric acid and sodium hydroxide to
various pH values ranging from 3.4 to 7.8 as shown below in Table 16. It was determined
that the pH value of 5.8 was optimal for permeation experiments, with most of the adefovir
taking the form of a hydrogenphosphonate monoanion with the tertiary amino group of
DDAK being its main proton source [49].




Figure 14. Adefovir and DDAK. 
2.3.5. Counter Ion Concentration 
The effects of adding excess amounts of counter ions to saturated solutions of their 
salt were considered by Pardo et al. [41] and are shown in Table 17. The consequences of 
increasing the amount of salicylate to achieve an 8:1 salicylate–PHY molar ratio in the 
donor compartment of a typical permeation study, caused a decrease in the solubility of 
the PHY-salicylate salt. Nonetheless, this had very little effect on the flux of PHY, that 
changed from 44.27 ± 9.16 to 48.40 ± 9.50 µmol cm−2 min−1. It did, on the other hand, in-
crease the flux of salicylate approximately 4 fold, from 61.66 ± 2.54 to 247.30 ± 36.50 µmol 
cm−2 min−1. 
Creating an excess instead, of PHY, resulted in the equivalent of a 6.5:1 molar ratio 
of PHY- salicylate in the donor solution. This change in proportion had no real impact on 
the flux of SA (61.66 ± 2.54 to 63.90 ± 7.00 µmol cm−2 min−1). It did, however, result in an 
increase in the flux of PHY by approximately 50% (44.27 ± 9.16 to 67.20 ± 7.70 µmol cm−2 
min−1). 
This relatively low increase in permeation when PHY concentration was increased, 
versus the lack of change in flux when PHY was decreased, might be explained by the 
ratio of PHY cations to salicylate anions. When the number of anions decreased, the PHY 
cations were more likely to bind to negatively charged groups present in the porcine mem-
brane thus limiting their movement. 
Table 17. Effect of solute composition on concentration (Cv), flux values and permeability coeffi-
cients of PHY and salicylate, when delivered through human skin (n ≥ 3 ≤ 8, values represent the 
mean ± S.E.M.). Adapted from [41], Wiley, 1992.. 
PHY: SA 
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Flux × 104 
(µmol cm−2 min−1) 
Permeability Coeffi-




 PHY salicylate PHY salicylate PHY salicylate 
1:1 44.27 ± 9.16 61.66 ± 2.54 1.86 ± 0.39 2.60 ± 0.10 23.70 ± 0.55 23.70 ± 0.55 
1:8 48.40 ± 9.50 
247.30 ± 
36.50 3.25 ± 0.64 2.10 ± 0.30 14.90 ± 0.40 
120.00 ± 
15.20 
6.5:1 67.20 ± 7.70 63.90 ± 7.00 0.44 ± 0.05 2.68 ± 0.30 153.40 ± 7.70 23.70 ± 3.40 
Vávrová et al. [49] also investigated the optimal quantity of the counter ion DDAK to 
be used in conjunction with adefovir, a zwitterionic drug used in the treatment of hepatitis 
B. This was done by maintaining the drug concentration at 2% and changing the amount 
of counter ion, DDAK, to 0, 0.5, 1, 2 and 3%. Permeation studies using porcine skin indi-
cated optimal flux values at 1% for DDAK, at which point flux values plateaued. This was 















Table 16. Flux and skin concentrati n of 2% adef vir with and without DDAK though porcine skin plotted against pH
(n = 4 for all experiments except pH 5.8 where n = 12, values represent the mean). Adapted from [49], Elsevier, 2008.
pH Values 3.4 3.8 4.8 5.8 6.8 7.8
Flux of Adefovir ~
(µg cm−2 h−1)
2% Adefovir 0.2 1 2 1 3 4
2% Adefovir + 1% DDAK 9.5 10 18 27 26.5 10
Adefovir Skin Concentration
~(µg g−1)
2% Adefovir 103 221 235 191 191 221
2% Adefovir + 1% DDAK 412 538 708 771 693 412
Pharmaceutics 2021, 13, 909 22 of 31
2.3.5. Counter Ion Concentration
The effects of adding excess amounts of counter ions to saturated solutions of their
salt were considered by Pardo et al. [41] and are shown in Table 17. The consequences of
increasing the amount of salicylate to achieve an 8:1 salicylate–PHY molar ratio in the donor
compartment of a typical permeation study, caused a decrease in the solubility of the PHY-
salicylate salt. Nonetheless, this had very little effect on the flux of PHY, that changed from
44.27 ± 9.16 to 48.40 ± 9.50 µmol cm−2 min−1. It did, on the other hand, increase the flux
of salicylate approximately 4 fold, from 61.66 ± 2.54 to 247.30 ± 36.50 µmol cm−2 min−1.
Table 17. Effect of solute composition on concentration (Cv), flux values and permeability coefficients of PHY and salicylate,









PHY salicylate PHY salicylate PHY salicylate
1:1 44.27 ± 9.16 61.66 ± 2.54 1.86 ± 0.39 2.60 ± 0.10 23.70 ± 0.55 23.70 ± 0.55
1:8 48.40 ± 9.50 247.30 ± 36.50 3.25 ± 0.64 2.10 ± 0.30 14.90 ± 0.40 120.00 ± 15.20
6.5:1 67.20 ± 7.70 63.90 ± 7.00 0.44 ± 0.05 2.68 ± 0.30 153.40 ± 7.70 23.70 ± 3.40
Creating an excess instead, of PHY, resulted in the equivalent of a 6.5:1 molar ratio of
PHY- salicylate in the donor solution. This change in proportion had no real impact on the flux
of SA (61.66 ± 2.54 to 63.90 ± 7.00 µmol cm−2 min−1). It did, however, result in an increase in
the flux of PHY by approximately 50% (44.27 ± 9.16 to 67.20 ± 7.70 µmol cm−2 min−1).
This relatively low increase in permeation when PHY concentration was increased,
versus the lack of change in flux when PHY was decreased, might be explained by the ratio
of PHY cations to salicylate anions. When the number of anions decreased, the PHY cations
were more likely to bind to negatively charged groups present in the porcine membrane
thus limiting their movement.
Vávrová et al. [49] also investigated the optimal quantity of the counter ion DDAK
to be used in conjunction with adefovir, a zwitterionic drug used in the treatment of
hepatitis B. This was done by maintaining the drug concentration at 2% and changing the
amount of counter ion, DDAK, to 0, 0.5, 1, 2 and 3%. Permeation studies using porcine skin
indicated optimal flux values at 1% for DDAK, at which point flux values plateaued. This
was demonstrated by the different amounts of permeant that surpassed the skin barrier
when maintaining the drug concentration at 2% and adjusting the amount of the counter
ion, DDAK. With DDAK: 0%, flux: 0 µg cm−2 h−1; DDAK: 0.5%, flux: 14 µg cm−2 h−1,
DDAK: 1%, flux: 27 µg cm−2 h−1, DDAK: 2%, flux: 26 µg cm−2 h−1 and when DDKA: 3%,
flux: 26.5 µg cm−2 h−1.
In 2011, Chirio et al. [50] used citric acid as a counter ion to increase the lipophilicity
of diltiazem at a 2% w/w concentration (as shown in Figure 15) in a thermosensitive gel
formulation. The different formulations devised by the authors included a 1.6% w/w
methylcellulose gel containing diltiazem either in the absence or presence of the counter
ion in a 1:4 ratio (diltiazem: citric acid). Results from permeation studies using porcine
skin showed that the flux of diltiazem increased from 1.8 ± 0.3 to 2.6 ± 0.5 µg cm−2 h−1
when applied with the counter ion. The skin accumulation of the active also increased from
85 ± 8 to 176 ± 11 µg cm−2 at 24 h. When the formulation was changed to a 16% w/w
Pluronic F127 gel, flux values for diltiazem in the absence of the counter ion were shown to
be 2.1 ± 0.4 µg cm−2 h−1, and 3.0 ± 0.5 µg cm−2 h−1 when the counter ion was included
at a 1:1 ratio. Skin accumulation also increased from 77 ± 6 to 151 ± 12 µg cm−2 after a
24 h permeation study. The change of polymeric continuous phase of these gels resulted
in a much lower concentration of counter ion being used to achieve similar permeation
outcomes, demonstrating the importance of different molecular environments for ion
pairing formation [50].
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Due to the challenges involved in delivering sufficient quantities of drugs through 
the skin, the issue of toxicity is rarely addressed. It was, however, considered by Vávrová 
et al. [49] who specifically limited the amount of adefovir to a maximum concentration of 
20 mg mL−1, in one set of experiments, despite drug solubility increasing up to as much as 
120 mg mL−1 at different pH values. Fini et al. [32] also cautioned against the potential 
toxicity of the aliphatic amine counter ions used in their 2012 studies, as these do accom-
pany the active when partitioning into the skin. 
2.3.6. Ion Pair and Penetration Enhancers 
Penetration Enhancers Used as Ion Pairs 
Green et al. [28] were the first to propose LA and OA as both counter ions and per-
meation enhancers in human skin studies in the late eighties. It was suggested that the 
enhanced flux of cationic naphazoline in conjunction with anionic fatty acids might be 
attributed to the increase in lipophilicity of naphazoline conveyed by ion pairing. This 
was confirmed by the results of PC studies shown previously in Table 1. 
The counter ion, DDAK, used by Vávrová et al. [49] in conjunction with adefovir had 
previously been shown to be an effective permeation enhancer. This was demonstrated 
with pre treatment of porcine skin by the counter ion in advance of the application of the 
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in one set of experiments, despite drug solubility increasing up to as much as 120 mg mL−1
at different pH values. Fini et al. [32] also cautioned against the potential toxicity of the
aliphatic amine counter ions used in their 2012 studies, as these do accompany the active
when partitioning into the skin.
2.3.6. Ion Pair and Penetration Enhancers
Penetration Enhancers Used as Ion Pairs
Green et al. [28] were the first to propose LA and OA as both counter ions and
permeation enhancers in human skin studies in the late eighties. It was suggested that
the enhanced flux of cationic naphazoline in conjunction with anionic fatty acids might be
attributed to the increase in lipophilicity of naphazoline conveyed by ion pairing. This was
confirmed by the results of PC studies shown previously in Table 1.
The counter ion, DDAK, used by Vávrová et al. [49] in conjunction with adefovir had
previously been shown to be an effective permeation enhancer. This was demonstrated
with pre treatment of porcine skin by the counter ion in advance of the application of the
adefovir solution, with results highlighted in Table 18. When combined with adefovir
in solution, the addition of 1% of DDAK significantly reduced the solubility of adefovir
at its optimal pH, 5.8, from ~124 to ~71 mg mL−1. The reduction in solubility was of
no consequence for this particular study, as the concentration was higher than that used
in previous permeation experiments. This combination resulted in the flux increasing
from ~16.5 to ~25.6 µg cm−2 h−1 in porcine skin experiments, when compared with pre-
treatment alone. When experiments were conducted with human skin using adefovir
alone, the authors observed that flux was “an order of magnitude lower” than it had been
through porcine skin, but when applied in conjunction with DDAK it increased by 179 fold,
from ~0.04 to 8.93 µg cm−2 h−1. As mentioned previously, the authors noted that at the
chosen pH value of 5.8, much of the adefovir was in the form of a hydrogenphosphonate
monoanion, whilst the tertiary amino group of DDAK was protonated. They suggested
that it was likely therefore, that ion pairing contributed to the reduction in solubility, and
to the increased flux of the drug.
Ion Pairs and the Inclusion of Penetration Enhancers
Auner et al. [36] combined the use of ALA and the counter ion, cetylpyridinium
chloride (CP) at pH 7, with a permeation enhancer, 6-ketocholestanol (KC). The permeation
enhancer was formulated into phosphatidylcholine liposomes. This combination increased
the flux of ALA by 3.5 fold from ~6.26 to ~23.00 µg/cm−2 after a period of 4 h as shown
in Table 19.
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Table 18. Flux and skin concentration of adefovir after use of DDAK (for human skin experiments n ≥ 3 ≤ 4, except for 2%
adefovir samples where n = 12, for porcine skin experiments n = 4, except for co-application samples where n = 12, values
represent the mean). Adapted from [49], Elsevier, 2008.
Membrane Application Flux~(µg cm−2 h−1)
Skin Concentration (Epidermins
Incl SC for Human Skin)~
Porcine skin
Co-application of 2% adefovir, 1% DDAK 25.6 31.3 µg g−1
2% adefovir pre-treatment of skin with DDAK 16.5 17.1 µg g−1
Human skin
Co-application of 2% adefovir, 1% DDAK 8.93 21.30 µg cm−2
2% adefovir no DDAK 0.04 5.72 µg cm−2
Table 19. Permeation of ALA through porcine skin with unloaded phosphatidylcholine liposomes; with CP counter ion and unloaded
phosphatidylcholine liposomes and with CP counter ion and KC loaded phosphatidylcholine liposomes. The concentration of ALA
applied in the buffer solutions was 0.4 mg mL (n ≥ 3 values represent the mean). Adapted from [36], Elsevier, 2003.
ALA with: pH Cumulative amount of ALA ~(µg/cm
−2) after 4 h
Using Porcine Skin
counter ion CP plus phosphatidylcholine
liposomes loaded with KC 7.0 23.00
counter ion CP plus unloaded
phosphatidylcholine liposomes 7.0 11.25
unloaded phosphatidylcholine liposomes 7.0 6.25
2.4. Ion Pairs and the Customisation of Drug Permeating Amounts
Ion pairs have been used in an attempt to increase drug flux through the skin. There
are occasions, however, where the permeation of active ingredients into the systemic
circulation is not desirable. Vasoconstrictors (VC) have been used as ion pairs in order
to increase the residence time of drugs in the skin and local tissues by reducing dermal
clearance [51]. Cross and co-workers tested three different VCs in a 1:1 molar ratio with
SA (Figure 16) using liquid paraffin as a vehicle (Table 20). These formulations were
then applied to a human abdominal epidermal membrane using conventional in vitro
permeation methodology. Analysis of flux values as well as skin retention of the SA and
VCs was then undertaken. It was found that following absorption into the membrane,
there were unequal molar ratios of the VC and the SA in both the membrane and the
receptor fluid. As shown in Table 20, there was greater epidermal flux and higher reten-
tion of the SA in conjunction with the VC, ephedrine. Flux of SA in combination with
ephedrine was 18.6 ± 0.6 µg cm−2 h−1, with naphazoline was 7.8 ± 0.8 µg cm−2 h−1 and
with tetrahydrozoline was 1.1 ± 0.1 µg cm−2 h−1. Skin retention of SA with ephedrine was
4.2 ± 0.7 µg mg−1; with naphazoline, it was 3.5 ± 1.1 µg mg−1; and with tetrahydrozoline,
it was 2.8 ± 1.1 µg mg−1.
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Table 20. Epidermal flux and tissue retention of VCs and SA following application to human skin.
Concentrations applied were 10% w/v of equimolar amounts of SA and VC (n = 6, values represent






VC SA VC SA
Ephedrine 11.5 ± 2.3 18.6 ± 0.6 10.0 ± 0.4 4.2 ± 0.7
Naphazoline 12.0 ± 1.6 7.8 ± 0.8 20.7 ± 6.0 3.5 ± 1.1
Tetrahydrozoline 2.9 ± 0.5 1.1 ± 0.1 3.7 ± 0.6 2.8 ± 1.1
In a previously discussed study by Trotta that required the maximum concentration of
the RA in the skin with minimal dermal clearance, valine methyl esters and phenylalanine
ethyl esters were shown to increase the permeation of the active through porcine skin as
shown in Table 21. When RA was used in conjunction with either of these counter ions
in two different oil in water microemulsions, RA permeation was reduced considerably,
from 0.13 ± 0.02 to less than 0.01 µg cm−2 h−1. There was also a corresponding increase
in skin accumulation from a minimum amount of 1.0 ± 0.2 µg cm−2 when RA permeated
alone, to 13.3 ± 2.10 µg cm−2 when combined with the phenylalanine ethyl esters in
microemulsion (a) as shown in Table 21. The overall increase in localised delivery using
the microemulsions with ion pairs was 4–5 fold that of RA alone. There was also a total
reduction in flux [35].
Table 21. Skin accumulation and flux of RA alone and in combination with various counter ions. Formulation used for
non-microemulsion studies was a 0.005% (w/w) RA in ethanol–pH 6.4 buffer solution (1:2 v/v), in the absence or presence of
counter ions in a 1: 50 molar ratio. Microemulsions contained 0.05% RA in the absence or presence of counter ions in a 1:
50 molar ratio. Microemulsion (a) comprised 56.7% water, 8.8% IPM, 5.3% Epikuron, 13.2% Oramix and 16.0% ethanol;
microemulsion (b)) comprised 64.3% water, 10.0% IPM, 11.0% Epikuron, 13.6% Oramix and 9.2% ethanol (n ≥ 3, values
represent the mean ± S.D.). Adapted with permission from [35], Elsevier, 2003.
RA with: Skin Accumulation after 24 h(µg cm−2)
Flux
(µg cm−2 h−1)
alone 1.0 ± 0.2 0.13 ± 0.02
tryptophan methyl ester hydrochloride 2.3 ± 0.6 0.19 ± 0.02
phenylalanine ethyl ester hydrochloride 3.4 ± 0.6 0.23 ± 0.03
valine methyl ester hydrochloride 3.7 ± 0.8 0.21 ± 0.03
Formulated as microemulsions oil in water microemulsions (a) and (b):
(a) alone as microemulsion 3.3 ± 0.50 0.05 ± 0.01
(a) phenylalanine ethyl ester hydrochloride 13.3 ± 2.10 <0.01
(a) valine methyl ester hydrochloride 8.7 ± 1.6 <0.01
(b) alone as microemulsion 2.3 ± 0.50 0.04 ± 0.01
(b) phenylalanine ethyl ester hydrochloride 12.6 ± 1.8 <0.01
(b) valine methyl ester hydrochloride 10.8 ± 1.5 <0.01
Another example of the use of a vasoconstrictor to enhance dermal accumulation was
introduced by Uchino et al. [50] when combining DIC with phenylephrine as a counter
ion (seen in Figure 17). After a 48 h in vitro permeation study, the cumulative amounts
of DIC that had permeated after applying DIC, or the ion pair complex, to pig skin were
76.1 ± 26.6 and 118.9 ± 45.8 µg cm−2, respectively. The amounts of DIC found in the
epidermis as a result of the same applications, were 3.34 ± 1.04 and 5.58 ± 1.43 µg mg−1,
respectively. The concentrations of DIC in the dermis were recorded as 0.35 ± 0.09 and
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0.45 ± 0.14 µg mg−1 for both neat DIC and the active when combined with phenylephrine
as an ion pair [50,52].
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Figure 17. DIC and phenylephrine counter ion.
An amino acid derivative, carnitine, has been investigated as a potential alternative
exfoliator, due to the side effects of conventional exfoliation methods [40]. As calcium is
important in the adhesion of corneocytes, a reduction in calcium ions in the skin reduces
cohesion of the corneocytes, thus improvi g exfoliation. The calcium chelating abilities of
carnitine were considered i a recent study by In et al. [40]. As an amphoteric molecule,
penetration of carnitine has been regarded as extremely limited. A zwitterionic counter ion,
hydrogenated soya phosphatidylcholine (HSC), was utilised to both increase partitioning
into the skin and to limit permeation to the epidermis. The percentage of applied carnitine
(4% w/w), found in the epidermal layers of porcine skin after a 24 h in vitro permeation
study was approximately 9.13% when carnitine was applied without any counter ion, and
23.71% when applied with HSC. In this study, no permeation beyond the epidermis was
seen, showing the potential of ion pairs in retention of skin compounds [40].
Recently, ion pairing was used in a novel fashion by Rodrigues and co-workers to
increase the lipophilicity of the hydrophobic drug, adapalene [53]. This molecule has been
used for the topical treatment of acne. However, patient compliance is poor because of skin
irritation. By encapsulating adapalene (0.1% w/w) in solid lipid nanoparticles (SLPs) in
conjunction with stearylamine as a counter ion (Figure 18), several improvements in the
formulation and delivery of adapalene were evident. According to the authors, crystals of
adapalene were no longer observed in the external aqueous phase of the formulation as a
result of efficient encapsulation due to ion pairing. While both compounds (i.e., adapalene
and stearylamine) were considered practically insoluble in water, the interaction between
these two molecular entities appeared to ensure that adapalene did not partition out of the
lipid phase. Furthermore, the SLP formulation resulted in 4-fold more adapalene in the
epidermis (16.36 ± 1.79 compared to 4.08 ± 0.22 µg cm−2) and 7-fold more retention in the
dermis (1.17 ± 0.12 compared to 0.16 ± 0.03 µg cm−2), than the marketed gel formulation
(0.1% w/w AD), in a porcine skin permeation study [53].
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2.5. Kinetics
The organic ion pair, PHY–salicylate salt, was studied in human skin by Pardo et al. [41].
Since diffusion of the individual ion species occurred at different rates, it was concluded
that while the diffusion of each component of the ion pair did follow Fick’s laws of diffusion,
the rate at which they occurred was influenced by a number of factors. These included
the pH of the membrane, the pKa of the individual molecules and the charge bearing
groups contained within the membrane. The authors suggested that the apparent net
negative charge of the skin at physiological pH, could explain the slower permeation of the
positively charged PHY.
In adjusting the molar ratios of the two species to determine the impact on perme-
ation, the authors found that increasing salicylate to achieve an 8:1 salicylate—PHY molar
ratio in the donor compartment of a typical permeation study, caused a decrease in the
solubility of the PHY-salicylate salt. Nonetheless, this had very little effect on the flux
of PHY, which changed from 44.27 ± 9.16 to 48.40 ± 9.50 µmol cm−2 min−1. It did, on
the other hand, increase the flux of salicylate approximately 4 fold, from 61.66 ± 2.54 to
247.30 ± 36.50 µmol cm−2 min−1. Creating an excess instead, of PHY, resulted in the equiv-
alent of a 6.5:1 molar ratio of PHY- salicylate in the donor solution. This change in propor-
tion had no real impact on the flux of SA (61.66 ± 2.54. to 63.90 ± 7.00 µmol cm−2 min−1).
It did, however, result in an increase in the flux of PHY by approximately 50% (44.27 ± 9.16
to 67.20 ± 7.70 µmol cm−2 min−1).
This relatively low increase in permeation when the PHY concentration was increased,
versus no change in flux when PHY was decreased, was explained by the ratio of PHY
cations to salicylate anions. When the number of anions decreased, the PHY cations
were more likely to bind to negatively charged groups present in the porcine membrane
thus limiting their movement. Conversely, the lack of positively charged groups in the
membrane would facilitate the flux of the salicylate ion.
Other contributory factors in relation to the permeation kinetics of the permeation
included solvent selection, combination and titration. The solvents IPA, with a ε of 18.62
at 20 ◦C [42,43], and IPM, with a ε of 3.31 at 25 ◦C [44], were mixed in various combi-
nations. As shown in Table 9, it was found that a solvent mixture comprising a 70:30
ratio of IPA to IPM had the best impact on permeation. Flux of PHY increased from
0.56 ± 0.08 × 104 µmol cm−2 m−1 at its lowest rate determined when the solvent com-
prised 100% of IPA, to 44.27 ± 9.16 × 104 µmol cm−2 m−1 when the solvent mixture
contained 70% IPA. Flux of salicylate increased from 1.47 ± 0.11 × 104 µmol cm−2 m−1
at its lowest rate, which occurred when the solvent comprised 100% IPM to
61.66 ± 2.54 µmol cm−2 m−1 when the optimal ratio of IPA to IPM was 70:30 [41].
2.6. Ion Pairs in Marketed Formulations
A commonly used NSAID, DIC, is generally formulated as a salt to overcome the
characteristic low solubility of the free acid. Salt forms such as sodium, epolamine (N-(2-
hydroxyethyl)pyrrolidine) and diethylamine have been shown to partition from aqueous
into lipid layers as ion pairs by Fini et al. [15,32]. These counter ions or salts are used in a
number of commercial formulations as presented in Table 22. Although other formulations
are available on the market, these are not included in the present document.
Table 22. Commercial applications of DIC and counter ions sodium, epolamine and diethylammonium.
Commercial Name Active Ion Pair Owner
Diclofenac 1% gel DFA Sodium A A H Pharmaceuticals Ltd.
Diclofenac 1% gel DFA Sodium Actavis UK Ltd.
Diclofenac 1% gel DFA Sodium Alliance Healthcare(Distribution) Ltd.
Diclofenac 1% gel DFA Sodium Typharm Ltd.
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Table 22. Cont.
Commercial Name Active Ion Pair Owner
Diclofenac sodium topical gel 1% DFA Sodium AvKARE
Diclofenac sodium topical gel 3% DFA Sodium Taro
Diclofenac sodium topical solution (1.5%) DFA Sodium Sola Pharmaceuticals
Flector gel 1% DFA Epolamine, sodium LaboratoiresGenevrier
Flector EP 10 mg/g DFA Epolamine Medichemie
Flector tissugel 140 mg (medicated plaster) DFA Sodium Windzor Pharma
Flector (patch) DFA Epolamine Pfizer
Pennsaid ®® (2% solution) DFA Sodium Horizon Medicines LLC
Solaraze 3% gel DFA Sodium Almirall Ltd.
Solacutan 3% gel DFA Sodium Mibe Pharma UK Ltd.
Voltarol®® joint pain relief 2.32% gel DFA diethylammonium GSK
Voltarol®® joint 12 h joint pain
relief 2.32% gel
DFA diethylammonium GSK
Voltarol®® osteoarthritis joint pain
relief 1.16% gel
DFA diethylammonium GSK
Voltarol®® back and muscle pain
relief 1.16% gel
DFA diethylammonium GSK
Voltarol®® 140 mg medicated plaster DFA Sodium GSK
3. Conclusions
The literature relating to ion pairs has been examined and critically considered with
the intention of elucidating common approaches used when employing ion pairing in the
delivery of drugs via the skin. Not all factors influencing ion pairing, such as hydrogen
bonding and solvation, were considered in the publications reviewed. Furthermore the
areas identified, while examined individually, can not be considered in isolation.
PC studies have often been undertaken to determine the ability of ions to form ion pairs
and these results have sometimes, but not always, translated into increased permeation
results. While outcomes of regression analyses and QSARs have shown that the PC, as
a measure of lipophilicity or hydrophobicity, is one of the most important predictors of
flux, this is not always the case. This is unsurprising, given that permeation relies on both
the partition and diffusion of molecules involved. Despite this, few studies considered the
retention of the drug in the biological membranes in addition to flux, when considering the
efficacy of PC experiments.
In terms of characteristics of the counter ion, experiments have confirmed that the
ability to form ion pairs is impacted by the distance between centres of charge. Ions of
a smaller radius, such as lithium, were better able to form ion pairs than those with a
larger radius, such as caesium. Other observations relating to the type of counter ion,
considered the degree of substitution of amine structures. The pairing efficiency of amine
counter ions in conjunction with SA, in human skin permeation studies, was observed to be
tertiary > secondary > primary > quaternary. Investigations also revealed organic cations
to be more successful than inorganic structures in forming ion pairs. Furthermore, it was
established that increasing the carbon chain length of the counter ion increased partitioning
and permeation through the skin. This was attributed to increased lipophilicity of the ion
pair when compared to their singular molecular constituents.
Authors have suggested that the contribution of ion pairing may be more than an
electrostatic interaction. In such cases, the hydrocarbon moieties of the functional groups
of counter ions may also contribute to masking or shielding the charges of the chemical
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composites. This conceptual experimental idea that longer alkyl chains could possibly
increase such masking or shielding, would indeed explain the variety of permeation data
shown by many authors.
General principles relating to solubility and the ability to partition or permeate have
been analysed. The comparison of structurally related counter ions, showed very clearly
that while those with hydroxy groups resulted in higher aqueous solubility, this did not
ordinarily translate into a higher permeation coefficient. It was confirmed that solubility
of a substance in its formulation does not ensure partition into a biological membrane.
Furthermore, it was indicated that where solubility parameters of the solute and the solvent
are too similar, it may be concluded that partitioning of the analyte into the membrane
is not assured. Importantly, it is essential to bear in mind that ion pairing strategies are
always subject to all factors affecting skin permeations.
As crucial components of semi-solid formulations, solvent systems with a reduced ε
value are more likely to stabilise ion pairs. The impact of different solvent combinations
on the permeation of counter ions was evaluated, as was the impact of different counter
ions or different quantities of counter ions, on the conductivity of the solution. However,
no information has been disclosed in recent studies regarding the conductivity of various
solvent systems when utilising the same counter ion combinations.
The impact of pH has also been considered by many authors in ion pair research.
Although the pH partition theory considers that only unionised drugs permeate the skin, it
is clear that some ionised drugs are in fact able to partition when charges are masked.
The important issue of toxicity was addressed in only two of the papers reviewed,
despite the significance of this matter when selecting potential counter ions. The authors
may have given no consideration to this matter, due to their experiments being initial
investigations into the ability of various ions to pair, and to the impact of different structures
on this ability. However, this is an important concern that should be addressed in the
selection process. Furthermore, the potential for skin related irritations did not appear
to be a factor when choosing possible counter ions in any of the studies reviewed. As
these formulations are to be applied topically, the likelihood of skin irritation must be
contemplated. One such example is benzalkonium chloride that is considered an irritant
when used at a concentration of 7.5% [54,55], thus use of this compound as a counter ion
should be limited.
The concept of ion pairs has developed in novel ways. This approach has not only
been explored to increase permeation through the skin, but to control or limit permeation
to the membrane itself. Permeation enhancers have been used as ion pairs, and ion pairs
have been used in conjunction with permeation enhancers.
Ion pairs have also been used to improve the stability of solid lipid nanoparticle
formulations. Thus, the formation of ion pairs is a versatile strategy, and one to be consid-
ered when formulating actives for topical and transdermal delivery. They should not be
examined in isolation, because as noted, they are subject to all the factors that impact the
application of drugs to or via the skin. In future investigations, it would be interesting to
consider not only the impact of the solvent ε value on the conductivity of the formulation,
but also to evaluate the importance of solubility parameters of analytes and solvents used
for such studies. This concept could potentially result in a formulation from which counter
ions would be more likely to partition into the membrane. Additionally, mass balance stud-
ies combined with conventional permeation studies should provide additional information
relating to the distribution of the pharmaceutical ingredient, bearing in mind the impact of
the solubility parameters of the membrane in relation to the movement of the permeant.
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